Product Name: CD8a Antibody (FITC), Mouse MAb
Immunogen: Recombinant Human CD8a protein
Mouse IgG1: Mouse IgG2a
Concentration: 5 μl/Test, 0.1 mg/ml
Formulation: Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Preparation: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD8a and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
Specificity: Human CD8a
Application: FCM
CAS NO.: 105558-26-7
Product: Ginsenoside Rh3
Storage: This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze !Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposa
Caption: Flow cytometric analysis of Human CD8A expression on human peripheral blood lymphocytes. Cells were stained with FITC-conjugated anti-Human CD8a and PE conjugated anti-Human CD3 (BD Pharmingen™ Cat. No. 561809). The dot plots were derived from events with
Background: T-cell surface glycoprotein CD8 alpha chain, also known as CD8a, is a single-pass type I membrane protein. The CD8 glycoprotein is expressed by thymocytes, mature T cells and natural killer (NK) cells and has been implicated in the recognition of monom
PubMed ID:http://jpet.aspetjournals.org/content/208/2/294